3SBIO (HKG: 1530) announced on September 14, 2026, that it utilized approximately HK$3.094 million to repurchase 200,000 of its own shares.
The buyback transaction underscores the company's ongoing capital management strategy, reflecting its commitment to enhancing shareholder value through strategic share repurchases.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.